{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:48:52Z","timestamp":1784825332160,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20GM103434"],"award-info":[{"award-number":["P20GM103434"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA024723"],"award-info":[{"award-number":["R01AA024723"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bbrc.2022.05.099","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T03:29:02Z","timestamp":1654918142000},"page":"84-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPAR\u03b1-mediated regulation of adipose tissue mass"],"prefix":"10.1016","volume":"619","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0759-445X","authenticated-orcid":false,"given":"Yunhui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongke","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2022.05.099_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114678","article-title":"PPARalpha agonist WY-14,643 induces adipose atrophy and fails to blunt chronic ethanol-induced hepatic fat accumulation in mice lacking adipose FGFR1","author":"Xu","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1194\/jlr.M058610","article-title":"FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice","volume":"56","author":"Zhao","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2022.05.099_bib3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molmet.2018.03.010","article-title":"FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest","volume":"11","author":"S\u00f8berg","year":"2018","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib5","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1053\/j.gastro.2014.07.044","article-title":"Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets","volume":"147","author":"Fisher","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2022.05.099_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbrc.2007.06.068","article-title":"PPARalpha is a key regulator of hepatic FGF21","volume":"360","author":"Lund\u00e5sen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2022.05.099_bib7","doi-asserted-by":"crossref","first-page":"10490","DOI":"10.1074\/jbc.M112.429852","article-title":"Retinoic acid receptor beta stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice","volume":"288","author":"Li","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2022.05.099_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbagen.2015.12.004","article-title":"Mapping the response of human fibroblast growth factor 21 (FGF21) promoter to serum availability and lipoic acid in HepG2 hepatoma cells","volume":"1860","author":"Xia","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2022.05.099_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tox.2017.01.016","article-title":"Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: the role of the PPAR\u03b1-FGF21 axis","volume":"379","author":"Chen","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.bbrc.2022.05.099_bib10","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"BetaKlotho is required for metabolic activity of fibroblast growth factor 21","volume":"104","author":"Ogawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2022.05.099_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2022.05.099_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2013.00194","article-title":"Stressed liver and muscle call on adipocytes with FGF21","volume":"4","author":"Luo","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib13","doi-asserted-by":"crossref","first-page":"E1736","DOI":"10.1152\/ajpendo.00122.2007","article-title":"PPARgamma regulates adipose triglyceride lipase in adipocytes in\u00a0vitro and in\u00a0vivo","volume":"293","author":"Kershaw","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2022.05.099_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2006-927368","article-title":"Lipid metabolism in the liver","volume":"45","author":"Canbay","year":"2007","journal-title":"Z.\u00a0Gastroenterol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2016.01.006","article-title":"FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and Brown adipose tissues","volume":"23","author":"Schlein","year":"2016","journal-title":"Cell Metabol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib16","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2022.05.099_bib17","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2022.05.099_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jhep.2010.12.034","article-title":"Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK","volume":"55","author":"Xu","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib19","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1111\/bph.12765","article-title":"Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease","volume":"171","author":"Dou","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-0632-1_14","article-title":"Effect OF chronic alcohol consumption ON ethanol and acetaldehyde metabolism","author":"Lieber","year":"1975","journal-title":"Alcohol Intoxication and Withdrawal"},{"key":"10.1016\/j.bbrc.2022.05.099_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.exger.2004.03.024","article-title":"Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization","volume":"39","author":"Zhu","year":"2004","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbrc.2022.05.099_bib23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metabol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22008221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X22008221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:20:12Z","timestamp":1757766012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X22008221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":23,"alternative-id":["S0006291X22008221"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.05.099","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alcoholic fatty liver is blunted by rFGF21 administration in mice lacking adipose FGFR1: The role of FGF21 in PPAR\u03b1-mediated regulation of adipose tissue mass","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2022.05.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}